Chemotherapy during pregnancy: What is really safe?

Lancet Oncology

Volumn 5, Issue 7, 2004, Pages 398-

  Peccatori, Fedro ^a   Martinelli, Giovanni ^a   Gentilini, Oreste ^a   Goldhirsch, Aron ^a  

^a EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE ANTIBIOTIC AGENT; ANTINEOPLASTIC AGENT; DOXORUBICIN; EPIRUBICIN; IDARUBICIN;

BREAST CANCER; CANCER PATIENT; CANCER REGISTRY; CANCER STAGING; CARDIOMYOPATHY; CARDIOTOXICITY; CHILDBIRTH; DRUG EFFICACY; DRUG GLUCURONIDATION; DRUG HALF LIFE; DRUG SAFETY; FEMALE; FETOTOXICITY; FETUS; HIGH RISK PATIENT; HUMAN; LIPOPHILICITY; MEDICAL DECISION MAKING; MEDICAL RECORD; NEWBORN; NOTE; PATIENT INFORMATION; PREGNANCY; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL;

EID: 3042773867     PISSN: 14702045     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1470-2045(04)01506-2     Document Type: Letter

References (10)

1. Cardonick E. Iacobucci A. Use of chemotherapy during human pregnancy Lancet Oncol. 5 2004 283-291
2. Corsini C. Ghielmini M. Mancuso P. et al. Idarubicinol myelotoxicity: a comparison of in vitro data with clinical outcome in patients treated with high-dose idarubicin Br. J. Cancer 82 2000 524-528
3. Mouridsen H.T. Alfthan C. Bastholt L. et al. Current status of Epirubicin in the treatment of solid tumors Acta Oncol. 29 1990 257-285
4. Camaggi C.M. Strocchi E. Comparsi R. et al. Biliary excretion and pharmacokinetics of 4′-epi-adriamycin in advanced cancer patients Cancer Chemother. Pharmacol. 18 1986 47-50
5. Kushari J. Mukherjea M. Studies on beta glucuronidase of the developing human placenta Gynecol. Obstet. Invest. 11 1980 119-127
6. Bonadonna G. Gianni L. Santoro A. et al. Drugs ten years later: epirubicin Ann Oncol 4 1993 359-369
7. Twelves C.J. O' Reilly S.M. Coleman R.E. et al. Weekly epirubicin for breast cancer liver metastases and abnormal liver biochemistry Br. J. Cancer 60 1989 938-941
8. Colozza M. Bisagni G. Mosconi A.M. et al. Epirubicin versus CMF as adjuvant therapy for stage I and II breast cancer: a prospective randomised study Eur. J. Cancer 38 2002 2279-2288
9. Germann N. Goffinet F. Goldwasser F. Anthracyclines during pregnancy: embryo-fetal outcome in 160 patients Ann. Oncol. 15 2004 146-150
10. Espie M. Cuvier C. Treating breast cancer during pregnancy. What can be taken safely? Drug Saf. 18 1998 135-142